Seems to go back to the discussion we were having a few weeks ago in that getting IND approval is not necessarily a strict path of requesting FDA approval before starting human trial. The trials can be started outside of FDA and as long as the data is relevant and strucrtured correctly it can be used for IND application at a later date. It would appear from Bpharma's post that this is exactly what they are doing.
Seems to go back to the discussion we were having a few weeks...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $161.7K | 556.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10451 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 12600 | 1 |
View Market Depth
| Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |